Photo: Depositphotos
Aug 3, 2025, 14:53
Daniel Morgenstern: Funding Changes Canadian Involvement in Children’s Oncology Group Trials
Daniel Morgenstern, Associate Professor at University of Toronto, shared a post on LinkedIn:
“Very sad that due to changes in funding rules, Canadian (and Australian) participation in the Children’s Oncology Group early phase trials portfolio has been suspended. Fingers crossed that we can find a way to work through this and again participate so that we can continue to maximise availability of novel therapies for Canadian children and contribute to scientific advances.”
More posts featuring Clinical Trials on OncoDaily.
-
Challenging the Status Quo in Colorectal Cancer 2024
December 6-8, 2024
-
ESMO 2024 Congress
September 13-17, 2024
-
ASCO Annual Meeting
May 30 - June 4, 2024
-
Yvonne Award 2024
May 31, 2024
-
OncoThon 2024, Online
Feb. 15, 2024
-
Global Summit on War & Cancer 2023, Online
Dec. 14-16, 2023
Aug 3, 2025, 14:23
Aug 3, 2025, 14:21
Aug 3, 2025, 12:31
Aug 3, 2025, 12:29
Aug 3, 2025, 12:13